New episodes every Tuesday!
GET NEW EPISODES TO YOUR EMAIL
Latest Episode
Living in the Now, with John Doe
Adipiscing elit dapibus, vulpu tate in donec tempor ultricies venenatis erat, aliquam posuere urna habitant rutrum iaculis Euismod maecenas varius. tortor nibh, sit amet tempor nibh finibus et. Aenean eu enim justo. Vestibulum aliquam
‘Her First 100K’ founder Tori Dunlap says investing right now is about managing your own panic
For Financial Literacy Month, Tori Dunlap spoke with MarketWatch about the investing hurdles women and young people face right now
Apple hasn’t gotten an ‘all clear’ on tariffs, but its stock is still surging
While Trump promises new tariffs for tech products, Apple seems to have avoided the worst-case scenario, as smartphones are exempt from the current reciprocal tariffs against China.
This is America’s ‘magic number’ for retirement – and it’s lower this year
Workers should replace 80% of their income for each year of retirement, new research suggests
Wegovy, Zepbound makers’ stocks rally as a weight-loss-drug competitor drops out
Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and Zepbound maker Eli Lilly a lift.
Goldman Sachs sees ‘strong’ earnings, powered by equities-trading revenue
Goldman Sachs reported revenue drops in two of its three main business lines, but trading revenue was enough to satisfy investors.
Central banks almost never say they intervene in currency markets. In a survey, half said they do.
Central banks rarely announce their interventions in currency markets — but one survey suggests they are very active despite pressure to keep out.
I begged my adviser to sell amid the market turmoil. It took him days and I lost $20,000. Can I sue?
“If he had moved my money out of the market weeks ago, much of my loss could have been prevented.”
World to America: We’re not dependent on trade with you anymore
The U.S. is not the trade titan that Trump believes it is.
America’s generic-drug crisis can be fixed in two words: pharma tariffs
Strong U.S. production isn’t just good economic policy; it’s about national security and public health.
Stay Tuned For Our Latest Episodes
Anean eu enim justo. Vestibulum aliquam hende rit molestie. Mauris malesuada nisi sit amet augue accumsan tincidunt. Maecenas tincidunt aliquam hende rit molestie. Mauris malesuada.
Start Listening Today!
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas varius tortor nibh, sit amet tempor nibh finibus et. Aenean eu enim justo. Vestibulum aliquam hendrerit